TrialPanorama/Dataset huggingface dataset:
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: H-SENSES PROJECT Self Care Mediated by the Senses: Assessing the Impact on Self-esteem, Stress and Well-being of Female Health Professionals
Brief Summary: Randomized clinical trial about self-care mediated by the senses in female health professionals and their influence on stress, self-esteem, mood states, life satisfaction and levels of salivary cortisol.


Options:
A: Arm Label: Nurse led intervention group; Type: EXPERIMENTAL; Interventions: Other: Nurse led intervention group | Arm Label: Control Group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: Nurse led intervention group; Assigned to Arm(s): Nurse led intervention group
B: Arm Label: A treatment based on CBT and new technologies; Type: EXPERIMENTAL; Interventions: Behavioral: Coping skills and relaxation training with new technologies | Arm Label: Traditional treatment based on CBT; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Traditional coping skills and relaxation training | Intervention Type: BEHAVIORAL; Name: Coping skills and relaxation training with new technologies; Assigned to Arm(s): A treatment based on CBT and new technologies | Intervention Type: BEHAVIORAL; Name: Traditional coping skills and relaxation training; Assigned to Arm(s): Traditional treatment based on CBT
C: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: one-sensory self care; Type: ACTIVE_COMPARATOR; Interventions: Other: one-sensory self care (Todo Dia®) | Arm Label: bi-sensory self care; Type: ACTIVE_COMPARATOR; Interventions: Other: bi-sensory self care (Todo Dia®) | Arm Label: multisensory self care; Type: ACTIVE_COMPARATOR; Interventions: Other: multisensory self care (Todo Dia®) | Intervention Type: OTHER; Name: one-sensory self care (Todo Dia®); Assigned to Arm(s): one-sensory self care | Intervention Type: OTHER; Name: multisensory self care (Todo Dia®); Assigned to Arm(s): multisensory self care | Intervention Type: OTHER; Name: bi-sensory self care (Todo Dia®); Assigned to Arm(s): bi-sensory self care
D: Arm Label: Mobile Video Counseling; Type: EXPERIMENTAL; Interventions: Behavioral: Stress management counseling | Arm Label: Offline Counseling; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Stress management counseling | Arm Label: Selfcare; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Stress management counseling; Assigned to Arm(s): Mobile Video Counseling, Offline Counseling

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Effect of Helicobacter Pylori Eradication on Glandular Atrophy and Metachronous Cancer in Patients Undergoing Endoscopic Mucosal Resection for Gastric Cancer
Brief Summary: This study evaluates whether Helicobacter pylori eradication improves precancerous lesions including glandular atrophy and intestinal metaplasia as well as metachronous cancers or dysplasias after endoscopic mucosal resection for gastric cancer.


Options:
A: Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo | Arm Label: LAC triple therapy; Type: ACTIVE_COMPARATOR; Interventions: Drug: LAC triple therapy | Intervention Type: DRUG; Name: Placebo; Assigned to Arm(s): Placebo | Intervention Type: DRUG; Name: LAC triple therapy; Assigned to Arm(s): LAC triple therapy
B: Arm Label: H pylori eradication; Type: ACTIVE_COMPARATOR; Interventions: Drug: Helicobacter pylori eradication | Intervention Type: DRUG; Name: Helicobacter pylori eradication; Assigned to Arm(s): H pylori eradication
C: Arm Label: 7 day H.pylori eradication; Type: ACTIVE_COMPARATOR; Interventions: Drug: 7 day H.pylori eradication Omeprazole or Rabeprazole, Clarithromycin, Amoxicillin | Arm Label: Placebo; Type: PLACEBO_COMPARATOR; Interventions: Drug: Placebo, Omeprazole or Rabeprazole, Clarithromycin | Intervention Type: DRUG; Name: 7 day H.pylori eradication Omeprazole or Rabeprazole, Clarithromycin, Amoxicillin; Assigned to Arm(s): 7 day H.pylori eradication | Intervention Type: DRUG; Name: Placebo, Omeprazole or Rabeprazole, Clarithromycin; Assigned to Arm(s): Placebo
D: Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: treatment group; Type: ACTIVE_COMPARATOR; Interventions: Drug: eradication treatment of Helicobacter pylori infection | Intervention Type: DRUG; Name: eradication treatment of Helicobacter pylori infection; Assigned to Arm(s): treatment group

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Collaborative Care for the Detection and Management of Depression Among Adults Receiving Antiretroviral Therapy in South Africa: a Pragmatic Cluster Randomized Controlled Trial
Brief Summary: With increasing access to antiretroviral therapy (ART) in South Africa, HIV has transitioned from a terminal illness to a long-term condition. It is likely to be accompanied by higher levels of disability and other chronic non-communicable diseases, resulting from the HIV itself, as well as adverse effects of medication. This requires an expansion of the purview of HIV care beyond direct HIV clinical care to also include a more comprehensive and integrated package of treatment and care for physical and mental conditions and their consequences. COBALT is a pragmatic cluster randomized controlled trial (RCT) in public sector primary care clinics in the North West Province of SA. It will assess mental health and HIV outcomes for depressed adults receiving ART by measuring the real-world effectiveness of a facility-based stepped care intervention combining depression case detection by non-physician clinicians with group counselling intervention delivered by lay-health workers.


Options:
A: Arm Label: Intervention women with partners; Type: EXPERIMENTAL; Interventions: Behavioral: Protect your family | Arm Label: Intervention women without partners; Type: EXPERIMENTAL; Interventions: Behavioral: Protect your family | Arm Label: Control women with partners; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Control women alone; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Protect your family; Assigned to Arm(s): Intervention women with partners, Intervention women without partners
B: Arm Label: Primary Care 101 Enhanced guideline; Type: EXPERIMENTAL; Interventions: Other: Primary care 101 plus mental health | Arm Label: Standard of care; Type: ACTIVE_COMPARATOR; Interventions: Other: Standard Primary Care 101 | Intervention Type: OTHER; Name: Primary care 101 plus mental health; Assigned to Arm(s): Primary Care 101 Enhanced guideline | Intervention Type: OTHER; Name: Standard Primary Care 101; Assigned to Arm(s): Standard of care
C: Arm Label: Integrated mental health in primary care; Type: EXPERIMENTAL; Interventions: Behavioral: Integrated mental health in primary care | Arm Label: Psychiatric nurse-led specialist care; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Psychiatric nurse-led specialist care | Intervention Type: BEHAVIORAL; Name: Integrated mental health in primary care; Assigned to Arm(s): Integrated mental health in primary care | Intervention Type: BEHAVIORAL; Name: Psychiatric nurse-led specialist care; Assigned to Arm(s): Psychiatric nurse-led specialist care
D: Arm Label: HAPIFED; Type: EXPERIMENTAL; Interventions: Behavioral: HAPIFED | Arm Label: CBT-E; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: CBT-E | Intervention Type: BEHAVIORAL; Name: HAPIFED; Assigned to Arm(s): HAPIFED | Intervention Type: BEHAVIORAL; Name: CBT-E; Assigned to Arm(s): CBT-E

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomised Controlled Trial of a Home-based Physical Activity Intervention in Breast Cancer Survivors
Brief Summary: The aim of this current study was to investigate the effects of a pragmatic home-based physical activity programme on primarily physical activity levels and secondarily weight maintenance, health-related quality of life (HRQoL), insulin resistance (IR) and lipid concentrations in post-adjuvant therapy breast cancer survivors.


Options:
A: Arm Label: Physical activity intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physical activity | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Physical activity; Assigned to Arm(s): Physical activity intervention
B: Arm Label: Control; Type: NO_INTERVENTION; Interventions: N/A | Arm Label: Exercise intervention; Type: EXPERIMENTAL; Interventions: Behavioral: 3 month physical activity intervention | Intervention Type: BEHAVIORAL; Name: 3 month physical activity intervention; Assigned to Arm(s): Exercise intervention
C: Arm Label: Soccer Training; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Soccer training | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Soccer training; Assigned to Arm(s): Soccer Training
D: Arm Label: core stability; Type: EXPERIMENTAL; Interventions: Other: core stability | Arm Label: control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: OTHER; Name: core stability; Assigned to Arm(s): core stability

Answer: A
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomised Controlled Trial of a Home-based Physical Activity Intervention in Breast Cancer Survivors
Brief Summary: The aim of this current study was to investigate the effects of a pragmatic home-based physical activity programme on primarily physical activity levels and secondarily weight maintenance, health-related quality of life (HRQoL), insulin resistance (IR) and lipid concentrations in post-adjuvant therapy breast cancer survivors.


Options:
A: Arm Label: Intervention group; Type: EXPERIMENTAL; Interventions: Behavioral: Psychosocial rehabilitation course | Arm Label: Control group; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Psychosocial rehabilitation course; Assigned to Arm(s): Intervention group
B: Arm Label: Physical activity intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physical activity | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Physical activity; Assigned to Arm(s): Physical activity intervention
C: Arm Label: Group I (yoga-based rehabilitation program); Type: EXPERIMENTAL; Interventions: Procedure: Quality-of-Life Assessment, Procedure: Yoga | Arm Label: Group II (standard care/control); Type: ACTIVE_COMPARATOR; Interventions: Procedure: Quality-of-Life Assessment, Procedure: Yoga | Intervention Type: PROCEDURE; Name: Quality-of-Life Assessment; Assigned to Arm(s): Group I (yoga-based rehabilitation program), Group II (standard care/control) | Intervention Type: PROCEDURE; Name: Yoga; Assigned to Arm(s): Group I (yoga-based rehabilitation program), Group II (standard care/control)
D: Intervention Type: BEHAVIORAL; Name: exercise intervention; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: complementary or alternative medicine procedure; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: fatigue assessment and management; Assigned to Arm(s): N/A | Intervention Type: PROCEDURE; Name: physical therapy; Assigned to Arm(s): N/A

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Randomised Controlled Trial of a Home-based Physical Activity Intervention in Breast Cancer Survivors
Brief Summary: The aim of this current study was to investigate the effects of a pragmatic home-based physical activity programme on primarily physical activity levels and secondarily weight maintenance, health-related quality of life (HRQoL), insulin resistance (IR) and lipid concentrations in post-adjuvant therapy breast cancer survivors.


Options:
A: Arm Label: Survivorship Intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Survivorship Intervention | Arm Label: Facing Forward; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Facing Forward | Intervention Type: BEHAVIORAL; Name: Survivorship Intervention; Assigned to Arm(s): Survivorship Intervention | Intervention Type: BEHAVIORAL; Name: Facing Forward; Assigned to Arm(s): Facing Forward
B: Arm Label: Physical activity intervention; Type: EXPERIMENTAL; Interventions: Behavioral: Physical activity | Arm Label: Usual care; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Physical activity; Assigned to Arm(s): Physical activity intervention
C: Arm Label: 1; Type: EXPERIMENTAL; Interventions: Behavioral: CBT and relaxation | Arm Label: 2; Type: EXPERIMENTAL; Interventions: Behavioral: Physical activity | Arm Label: 3; Type: EXPERIMENTAL; Interventions: Behavioral: CBT and physical activity | Arm Label: 4; Type: NO_INTERVENTION; Interventions: Other: Control group | Intervention Type: BEHAVIORAL; Name: CBT and relaxation; Assigned to Arm(s): 1 | Intervention Type: BEHAVIORAL; Name: Physical activity; Assigned to Arm(s): 2 | Intervention Type: BEHAVIORAL; Name: CBT and physical activity; Assigned to Arm(s): 3 | Intervention Type: OTHER; Name: Control group; Assigned to Arm(s): 4
D: Arm Label: Linear Aerobic Training; Type: EXPERIMENTAL; Interventions: Behavioral: Linear Aerobic Training, Other: Cardiopulmonary exercise test (CPET), Other: Blood draws | Arm Label: Nonlinear Aerobic Training; Type: EXPERIMENTAL; Interventions: Behavioral: Nonlinear Aerobic Training, Other: Cardiopulmonary exercise test (CPET), Other: Blood draws | Arm Label: Progressive Stretching Group (Attention control); Type: EXPERIMENTAL; Interventions: Behavioral: Progressive Stretching, Other: Cardiopulmonary exercise test (CPET), Other: Blood draws | Intervention Type: BEHAVIORAL; Name: Linear Aerobic Training; Assigned to Arm(s): Linear Aerobic Training | Intervention Type: BEHAVIORAL; Name: Nonlinear Aerobic Training; Assigned to Arm(s): Nonlinear Aerobic Training | Intervention Type: BEHAVIORAL; Name: Progressive Stretching; Assigned to Arm(s): Progressive Stretching Group (Attention control) | Intervention Type: OTHER; Name: Cardiopulmonary exercise test (CPET); Assigned to Arm(s): Linear Aerobic Training, Nonlinear Aerobic Training, Progressive Stretching Group (Attention control) | Intervention Type: OTHER; Name: Blood draws; Assigned to Arm(s): Linear Aerobic Training, Nonlinear Aerobic Training, Progressive Stretching Group (Attention control)

Answer: B
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Induction With Misoprostol: Oral Mucosa Versus Vaginal Epithelium
Brief Summary: The primary objective of this study is to compare the efficacy and safety of vaginal and buccal misoprostol for women undergoing labor induction at greater than or equal to 37+ 0 completed weeks gestation. Thus, the investigators have both efficacy and a safety primary outcomes.

The secondary objective of this study is to assess the pharmacokinetic(PK) parameters with these two routes of administration in a sub-cohort of this trial. The long term objective of this line of research is to inform providers' clinical decision making for the large number of women having labor induction. By providing robust PK and pharmacodynamic (PD) evaluation, clinical outcomes data for these two routes of administration, clinicians will be informed for evidence-based decisions about the preferred route of administration of misoprostol.


Options:
A: Arm Label: Oral Titrated Misoprostol Solution; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Arm Label: Vaginal Misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Oral Titrated Misoprostol Solution | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Vaginal Misoprostol
B: Arm Label: Oral misoprostol; Type: EXPERIMENTAL; Interventions: Drug: Misoprostol | Arm Label: Vaginal misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): Oral misoprostol, Vaginal misoprostol
C: Arm Label: misoprostol; Type: ACTIVE_COMPARATOR; Interventions: Drug: Misoprostol | Arm Label: dinoprostone; Type: ACTIVE_COMPARATOR; Interventions: Drug: Dinoprostone | Intervention Type: DRUG; Name: Misoprostol; Assigned to Arm(s): misoprostol | Intervention Type: DRUG; Name: Dinoprostone; Assigned to Arm(s): dinoprostone
D: Arm Label: misoprostol/placebo using buccal; Type: PLACEBO_COMPARATOR; Interventions: Drug: misoprostol/placebo | Arm Label: misoprostol/placebo using vaginal; Type: PLACEBO_COMPARATOR; Interventions: Drug: misoprostol/placebo | Intervention Type: DRUG; Name: misoprostol/placebo; Assigned to Arm(s): misoprostol/placebo using buccal, misoprostol/placebo using vaginal

Answer: D
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Assistive Device Training for Functional Mobility and Connectivity in Multiple Sclerosis
Brief Summary: The purpose of this study is to determine whether a training program in the use of ambulatory assistive devices (such as canes, walkers, etc) can reduce falls and increase functional mobility and neural connectivity in people with Multiple Sclerosis.


Options:
A: Arm Label: Sensory-motor Integration Training; Type: EXPERIMENTAL; Interventions: Procedure: Sensory-motor Integration Training | Arm Label: Conventional neurorehabilitation; Type: ACTIVE_COMPARATOR; Interventions: Procedure: Conventional neurorehabilitation treatment | Intervention Type: PROCEDURE; Name: Sensory-motor Integration Training; Assigned to Arm(s): Sensory-motor Integration Training | Intervention Type: PROCEDURE; Name: Conventional neurorehabilitation treatment; Assigned to Arm(s): Conventional neurorehabilitation
B: Arm Label: Group balance training early start; Type: EXPERIMENTAL; Interventions: Other: Group balance training | Arm Label: Group balance training late start; Type: EXPERIMENTAL; Interventions: Other: Group balance training | Intervention Type: OTHER; Name: Group balance training; Assigned to Arm(s): Group balance training early start, Group balance training late start
C: Arm Label: Training group; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Assistive Device Training | Arm Label: Wait-list control; Type: NO_INTERVENTION; Interventions: N/A | Intervention Type: BEHAVIORAL; Name: Assistive Device Training; Assigned to Arm(s): Training group
D: Arm Label: Free From Falls; Type: ACTIVE_COMPARATOR; Interventions: Behavioral: Free From Falls Online | Arm Label: Waitlist; Type: PLACEBO_COMPARATOR; Interventions: Behavioral: Waitlist Control | Intervention Type: BEHAVIORAL; Name: Free From Falls Online; Assigned to Arm(s): Free From Falls | Intervention Type: BEHAVIORAL; Name: Waitlist Control; Assigned to Arm(s): Waitlist

Answer: C
Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Vaccine Responses in Infants After Acellular Pertussis Vaccination During Pregnancy in Thailand
Brief Summary: Young infants are most vulnerable to severe disease and even death when infected with Bordetella pertussis. The current vaccines and vaccination programs do not guarantee protection of neonates from this disease. Maternal acquired pertussis-specific antibodies show low concentrations with short persistence in newborns creating a susceptibility gap for infection between birth and the first vaccinations. A possible strategy to protect infants from birth is pertussis vaccination during pregnancy, which will increase the amount of passively transferred maternal antibodies.

However, little is known regarding the effect of high titers of maternal antibodies on the infants immune responses to different pertussis vaccines (whole cell versus acellular). Humoral immune responses will be assessed in infants receiving whole cell versus infants receiving acellular pertussis vaccines. Functionality of the antibodies will also be analyzed.


Options:
A: Arm Label: Group 1: DTaP-IPV-Hep B-PRP-T; Type: EXPERIMENTAL; Interventions: Biological: DTaP-IPV-HB-PRP~T | Arm Label: Group 2: Tritanrix-Hep B/Hib™+OPV; Type: ACTIVE_COMPARATOR; Interventions: Biological: Tritanrix-HepB/Hib | Intervention Type: BIOLOGICAL; Name: DTaP-IPV-HB-PRP~T; Assigned to Arm(s): Group 1: DTaP-IPV-Hep B-PRP-T | Intervention Type: BIOLOGICAL; Name: Tritanrix-HepB/Hib; Assigned to Arm(s): Group 2: Tritanrix-Hep B/Hib™+OPV
B: Arm Label: Group A; Type: EXPERIMENTAL; Interventions: Biological: Boostrix, Biological: Infanrix hexa | Arm Label: Group B; Type: ACTIVE_COMPARATOR; Interventions: Biological: Boostrix, Biological: Quinvaxem, Biological: OPV | Intervention Type: BIOLOGICAL; Name: Boostrix; Assigned to Arm(s): Group A, Group B | Intervention Type: BIOLOGICAL; Name: Infanrix hexa; Assigned to Arm(s): Group A | Intervention Type: BIOLOGICAL; Name: Quinvaxem; Assigned to Arm(s): Group B | Intervention Type: BIOLOGICAL; Name: OPV; Assigned to Arm(s): Group B
C: Arm Label: Allergy Cases; Type: N/A; Interventions: N/A | Arm Label: Controls; Type: N/A; Interventions: N/A
D: Arm Label: Phase A - SI; Type: EXPERIMENTAL; Interventions: Biological: Bordetella Pertussis B1917, Drug: Azithromycin 500 mg | Arm Label: Phase B Inoculum; Type: EXPERIMENTAL; Interventions: Biological: Bordetella Pertussis B1917, Drug: Azithromycin 500 mg | Arm Label: Phase B Sham; Type: EXPERIMENTAL; Interventions: Drug: Azithromycin 500 mg, Other: Sterile Saline | Intervention Type: BIOLOGICAL; Name: Bordetella Pertussis B1917; Assigned to Arm(s): Phase A - SI, Phase B Inoculum | Intervention Type: DRUG; Name: Azithromycin 500 mg; Assigned to Arm(s): Phase A - SI, Phase B Inoculum, Phase B Sham | Intervention Type: OTHER; Name: Sterile Saline; Assigned to Arm(s): Phase B Sham

Answer: B